89 related articles for article (PubMed ID: 6630411)
1. Different rebound rise in plasma prolactin during the postdopamine infusion phase in puerperal women and patients with pathological hyperprolactinemia.
Genazzani AR; Cavagnini F; Picotti GB; Ghigo E; De Leo V; Galva MD; Maraschini C; Muller EE
J Clin Endocrinol Metab; 1983 Dec; 57(6):1159-63. PubMed ID: 6630411
[TBL] [Abstract][Full Text] [Related]
2. Prolactin lowering effect of amphetamine in normoprolactinemic subjects and in physiological and pathological hyperprolactinemia.
DeLeo V; Cella SG; Camanni F; Genazzani AR; Müller EE
Horm Metab Res; 1983 Sep; 15(9):439-43. PubMed ID: 6642414
[TBL] [Abstract][Full Text] [Related]
3. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
[TBL] [Abstract][Full Text] [Related]
4. Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women.
Melis GB; Gambacciani M; Paoletti AM; Beneventi F; Mais V; Baroldi P; Fioretti P
J Clin Endocrinol Metab; 1987 Sep; 65(3):541-5. PubMed ID: 3624413
[TBL] [Abstract][Full Text] [Related]
5. Prolactin-releasing effect of domperidone in normoprolactinemic and hyperprolactinemic subjects.
Camanni F; Genazzani AR; Massara F; La Rosa R; Cocchi D; Müller EE
Neuroendocrinology; 1980; 30(1):2-6. PubMed ID: 7354887
[TBL] [Abstract][Full Text] [Related]
6. Nomifensine: diagnostic test in hyperprolactinemic states.
Müller EE; Genazzani AR; Murru S
J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of a low dose dopamine infusion on prolactin secretion in normal and hyperprolactinemic subjects.
Serri O; Kuchel O; Buu NT; Somma M
J Clin Endocrinol Metab; 1983 Feb; 56(2):255-9. PubMed ID: 6822635
[TBL] [Abstract][Full Text] [Related]
8. Catecholamines and pituitary function. 2. Prolactin response to different dopamine doses in normal cycling women and patients with prolactin-secreting pituitary tumors, both before and after endogenous catecholamine synthesis inhibition.
Nicoletti I; Filipponi P; Fedeli L; Gregorini G; Ambrosi F; Sfrappini M; Santeusanio F; Brunetti P
Horm Metab Res; 1984 Dec; 16(12):658-62. PubMed ID: 6441763
[TBL] [Abstract][Full Text] [Related]
9. Effects of dopamine infusion on pituitary hormone secretion in humans.
Leblanc H; Lachelin GC; Abu-Fadil S; Yen SS
J Clin Endocrinol Metab; 1976 Sep; 43(3):668-74. PubMed ID: 956350
[TBL] [Abstract][Full Text] [Related]
10. Integrity of central dopaminergic system in women with postpartum hyperprolactinemia.
Rao R; Scommegna A; Frohman LA
Am J Obstet Gynecol; 1982 Aug; 143(8):883-7. PubMed ID: 7102764
[TBL] [Abstract][Full Text] [Related]
11. Dopamine infusion studies in patients with pathological hyperprolactinemia: evidence of normal prolactin suppressibility but abnormal dopamine metabolism.
Ho KY; Smythe GA; Duncan M; Lazarus L
J Clin Endocrinol Metab; 1984 Jan; 58(1):128-33. PubMed ID: 6689678
[TBL] [Abstract][Full Text] [Related]
12. Catecholamines and pituitary function. VI. Effect of different dopamine doses on TRH-induced prolactin release in women with pathological hyperprolactinemia.
Nicoletti I; Ambrosi F; Pagliacci MC; Pelicci G; Giammartino C; Maggio D; Fedeli L; Filipponi P
Horm Metab Res; 1987 Mar; 19(3):125-9. PubMed ID: 3106177
[TBL] [Abstract][Full Text] [Related]
13. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
Serri O; Beauregard H; Somma M; Comtois R; Jilwan N; Hardy J
Clin Invest Med; 1988 Dec; 11(6):387-91. PubMed ID: 3229037
[TBL] [Abstract][Full Text] [Related]
14. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
Fine SA; Frohman LA
J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
[TBL] [Abstract][Full Text] [Related]
15. Effect of sulpiride on plasma prolactin levels in women with puerperal or pathological hyperprolactinaemia.
Massara F; Camanni F; Belforte L; Campagnoli C; Novi RF; Molinatti GM
Acta Endocrinol (Copenh); 1980 Oct; 95(2):145-50. PubMed ID: 7435113
[TBL] [Abstract][Full Text] [Related]
16. Prolactin-secreting adenomas in women. VII. Dopamine regulation of prolactin secretion.
Martin MC; Weiner RI; Monroe SE; Roberts JM; Licko V; Jaffe RB
J Clin Endocrinol Metab; 1984 Sep; 59(3):485-90. PubMed ID: 6746862
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of hypothalamic hyperprolactinemia.
Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
[TBL] [Abstract][Full Text] [Related]
18. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
[TBL] [Abstract][Full Text] [Related]
19. [Plasma prolactin response to suckling stimulation in puerperal women].
Masaoka K; Niibe T; Kumasaka T; Saito M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):37-43. PubMed ID: 6699448
[TBL] [Abstract][Full Text] [Related]
20. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]